[PDF][PDF] Peroxisome proliferator-activated receptors and renal diseases
J Wu, L Chen, D Zhang, M Huo, X Zhang… - Front Biosci …, 2009 - article.imrpress.com
J Wu, L Chen, D Zhang, M Huo, X Zhang, D Pu, Y Guan
Front Biosci (Landmark Ed), 2009•article.imrpress.comIntroduction 3. PPARs: ligands and biological roles 4. PPAR ligands: clinical implications
and side effects 5. PPARs: intrarenal localization 6. PPARs: therapeutic role in renal
diseases 6.1. PPARα and renal disease 6.1. 1. PPARα and diabetic nephropathy 6.1. 2.
PPARα and acute renal failure 6.1. 3. PPARα and glomerulonephritis 6.2. PPARδ and renal
disease 6.3. PPARγ and renal disease 6.3. 1. PPARγ and diabetic nephropathy 6.3. 2.
PPARγ and renal cell carcinoma 6.3. 3. PPARγ and other kidney diseases 7. Conclusion
and side effects 5. PPARs: intrarenal localization 6. PPARs: therapeutic role in renal
diseases 6.1. PPARα and renal disease 6.1. 1. PPARα and diabetic nephropathy 6.1. 2.
PPARα and acute renal failure 6.1. 3. PPARα and glomerulonephritis 6.2. PPARδ and renal
disease 6.3. PPARγ and renal disease 6.3. 1. PPARγ and diabetic nephropathy 6.3. 2.
PPARγ and renal cell carcinoma 6.3. 3. PPARγ and other kidney diseases 7. Conclusion
Abstract
Introduction 3. PPARs: ligands and biological roles 4. PPAR ligands: clinical implications and side effects 5. PPARs: intrarenal localization 6. PPARs: therapeutic role in renal diseases 6.1. PPARα and renal disease 6.1. 1. PPARα and diabetic nephropathy 6.1. 2. PPARα and acute renal failure 6.1. 3. PPARα and glomerulonephritis 6.2. PPARδ and renal disease 6.3. PPARγ and renal disease 6.3. 1. PPARγ and diabetic nephropathy 6.3. 2. PPARγ and renal cell carcinoma 6.3. 3. PPARγ and other kidney diseases 7. Conclusion
article.imrpress.com
